Summary MedinCell SA (MedinCell) is a developer of therapeutic solutions for the healthcare market.The company develops and commercializes BEPO, a technology based on custom proprietary copolymers and a biocompatible solvent for long acting injectables.
Its BEPO provides a controlled release of therapeutic molecules and can be used to improve the treatment for a variety of chronic diseases or short-term illnesses.MedinCell provides peptides and proteins delivery services.
MedinCell offers products for various indications including schizophrenia, pain and inflammation, depression, anaesthesia, organ transplant, and others.The company works for profit and non-profit projects, and collaborates with partners including pharmas, physicians, biotech firms, academics and foundations.
MedinCell is headquartered in Jacou, France.
MedinCell SA (MEDCL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
206 pages •
By The Business Research Company
• Dec 2020
Pegfilgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID 19 Impact And Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global pegfilgrastim biosimilars market. Description: Where is the largest and fastest growing...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Rubber Gloves Market Report The rubber gloves market by revenue is expected to grow at a CAGR of over 13% during the period 2021–2026. The global rubber gloves market by revenue is expected to witness 2.1X times the growth during the...
Hematology Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Hematology Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Hematology Tests pipeline products with comparative analysis of the products at various stages...
Alopecia Areata Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Alopecia Areata Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Alopecia Areata Clinical trials scenario.This report provides top line data relating to the clinical trials...
Leishmaniasis (Kala-Azar) - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Leishmaniasis - Pipeline Review, H2 2020, provides an overview of the Leishmaniasis (Infectious Disease) pipeline landscape. Leishmaniasis is an infection caused by a parasite...
Immunochemistry Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Immunochemistry Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Immunochemistry Rapid Tests & POC pipeline products...
The Global Companion Diagnostics Partnering Terms and Agreements 2010-2020 report provides comprehensive understanding and unprecedented access to the companion diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in companion diagnostics partnering deals Companion...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.